Theraclion SA logo

Theraclion SA (TCLIF)

Market Closed
7 Aug, 20:00
OTC PINK OTC PINK
$
0. 53
0
0%
$
- Market Cap
- P/E Ratio
- Div Yield
100 Volume
0 Eps
$ 0.53
Previous Close
Add Transaction
Day Range
0 0.59
Year Range
0 0.59
Want to track TCLIF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

TCLIF closed Friday higher at $0.53, an increase of 0% from Thursday's close, completing a monthly decrease of 0% or $0. Over the past 12 months, TCLIF stock gained 312,841.1765%.
TCLIF is not paying dividends to its shareholders.
The last earnings report, released on Apr 27, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Theraclion SA has completed 1 stock splits, with the recent split occurring on Oct 30, 2013.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on XSTU (EUR).

TCLIF Chart

Theraclion SA (TCLIF) FAQ

What is the stock price today?

The current price is $0.53.

On which exchange is it traded?

Theraclion SA is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is TCLIF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Theraclion SA ever had a stock split?

Theraclion SA had 1 splits and the recent split was on Oct 30, 2013.

Theraclion SA Profile

Health Care Technology Industry
Healthcare Sector
Mr. Yann M. Duchesne CEO
OTC PINK Exchange
FR0010120402 ISIN
FR Country
28 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Founded in 2004 and based in Malakoff, France, Theraclion SA is a pioneer in the field of echotherapy solutions, utilizing high-intensity focused ultrasound (HIFU) technology. The company specializes in developing innovative, non-invasive medical devices aimed at improving treatment options for various conditions. With a focus on robotic technology, Theraclion's products offer precision and ease of use for both medical practitioners and patients, aligning with the modern healthcare objective of enhancing treatment outcomes while minimizing patient discomfort and recovery time.

Products and Services

  • SONOVEIN
  • SONOVEIN is Theraclion's pioneering robotic solution designed for the non-invasive echotherapy treatment of varicose veins. Leveraging high-intensity focused ultrasound, SONOVEIN provides a cutting-edge alternative to traditional surgical procedures, offering patients a less painful and faster recovery treatment option, without the need for incisions or general anesthesia.

  • ECHOPULSE
  • ECHOPULSE represents Theraclion’s advanced, robotic, and non-invasive solution aimed at the echotherapy treatment of thyroid nodules and breast fibroadenoma. Through its precise ultrasound technology, ECHOPULSE targets and treats affected tissues with minimal impact on surrounding healthy tissues, which contributes to quicker patient recovery and less post-operative complications compared to conventional surgical methods.

  • EPack
  • The EPack is a specially designed disposable that attaches to Theraclion's devices prior to the treatment. It serves a dual purpose: protecting the patient's skin during the echotherapy procedure and optimizing the quality of the ultrasound image. The usage of EPack is indicative of Theraclion's commitment to patient safety and the maximization of treatment efficacy through technological innovation.

Contact Information

Address: 244, avenue Pierre Brossolette, Malakoff, France, 92240
Phone: 33 1 55 48 90 70